Anew Medical, Inc. (WENA)

NASDAQ: WENA · IEX Real-Time Price · USD
-0.078 (-5.06%)
Jul 19, 2024, 11:41 AM EDT - Market open
Market Cap 22.24M
Revenue (ttm) n/a
Net Income (ttm) -2.50M
Shares Out 15.13M
EPS (ttm) -0.17
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 179,146
Open 1.570
Previous Close 1.540
Day's Range 1.460 - 1.570
52-Week Range 1.360 - 13.100
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Aug 15, 2024

About WENA

Anew Medical, Inc., a biopharmaceutical company, develops therapies for neurological and age-related disorders, and specialty diagnostics. Its products include cell and gene therapies to mitigate age-related pathologies, such as dementia symptoms, and Alzheimer and neuromuscular diseases; biologics/biosimilars in the treatment of cancer; and melanocortin receptors. The company has a strategic partnership with Japan’s Okinawa Research Center for the research and development of Klotho gene therapy in enhancing longevity and reducing age-related d... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2019
Employees 1
Stock Exchange NASDAQ
Ticker Symbol WENA
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements


ANEW MEDICAL, INC. Secures Key Patent in Europe for Human Klotho Gene RNA Slice Variant and Protein

ANEW to explore therapeutics and specialty diagnostics utilizing the s-KL protein and will pursue other medical product development and commercial opportunities of interest Exclusive, worldwide intell...

23 days ago - GlobeNewsWire